Invention Grant
- Patent Title: Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor
-
Application No.: US15027489Application Date: 2014-10-07
-
Publication No.: US09931401B2Publication Date: 2018-04-03
- Inventor: Atsushi Urano , Yasuki Kamai
- Applicant: Daiichi Sankyo Company, Limited
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Company, Limited
- Current Assignee: Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2013-211355 20131008
- International Application: PCT/JP2014/077276 WO 20141007
- International Announcement: WO2015/053407 WO 20150416
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K45/06 ; A61K31/47 ; A61K31/496 ; A61K31/44 ; A61K31/5025 ; A61K31/506 ; A61K31/53 ; C07K16/28 ; C07K16/30 ; A61K39/00
Abstract:
The present invention provides a combination of an antibody binding to a fibroblast growth factor receptor, and another agent.
Public/Granted literature
- US20160317656A1 COMBINATION OF ANTI-FGFR2 ANTIBODY AND OTHER AGENT Public/Granted day:2016-11-03
Information query
